Weight gain and hypertension: The chicken-egg question revisited

Journal of Hypertension

Volumn 22, Issue 10, 2004, Pages 1869-1871

  Calhoun, David A ^a,d   Grassi, Guido ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c IRCCS   (Italy)

^d 520 ZRB ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR;

BETA ADRENERGIC STIMULATION; DISEASE EXACERBATION; EDITORIAL; ENERGY EXPENDITURE; HUMAN; HYPERTENSION; OBESITY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RISK FACTOR; SYMPATHETIC TONE; THERMOGENESIS; WEIGHT GAIN;

EID: 5044240635     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200410000-00007     Document Type: Editorial

References (25)

1. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk Arch Intern Med 2002; 162:1867-1872.
2. Lee JS, Kawakubo K, Kashihara H, Mori K. Effect of long-term body weight change on the incidence of hypertension in Japanese men and women. Int J Obes Relat Metab Disord 2004; 28:391-395.
3. Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, et al. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEWIT). Hypertension 2002; 40:612-618.
4. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease. Curr Opin Cardiol 1996; 11:490-495.
5. Kannel WB, Brand N, Skinner JJ Jr, Dawber TE, McNamara PM. The relation between adiposity to blood pressure and development of hypertension. The Framingham Study. Ann Intern Med 1967; 67:48-59.
6. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990; 264:3534-3358.
7. Grassi G. Role of the sympathetic nervous system in hypertension. J Hypertens 1998; 16:1979-1987.
8. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429.
9. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17:1125-1133.
10. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1988; 14:1277-1283.
11. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36:538-542.
12. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G. Effects of hypertension and obesity on the sympathetic activation of heart failure patients. Hypertension 2003; 42:873-877.
13. Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street? Hypertension 2000; 35:807-813.
14. Valentini M, Julius S, Palatini P, Brook RD, Bard RL, Bisognano JD, et al. Attenuation of hemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004; 22:1999-2006.
15. Ravussin E, Bogardus C. A brief overview of human energy metabolism and its relationship to essential obesity Am J Clin Nutr 1992; 55 (suppl):242S-245S.
16. Troisi RJ, Scott TW, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991; 17:669-677.
17. Scherrer U, Randin D, Tappy L, Vollenweider MD, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89:2634-2640.
18. Poehlmann ET, Gardner AW, Goran MI, Arciero PJ, Toth MJ, Ades PA, et al. Sympathetic nervous system activity, body fatness, and body distribution in younger and older males. J Appl Physiol 1995; 78:802-806.
19. Paolisso G, Manzella D, Ferrara N, Gambardella A, Abetet P, Tagliamonte MR, et al. Glucose ingestion affects cardiac ANS in health subjects with different amounts of body fat. Am J Physiol 1997; 273:E471-E478.
20. Bertel O, Buhler FR, Kiowski W, Lutold BE. Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980; 2:130-138.
21. Wilhelmsen L, Berglund G, Elmfeldt D, Fitzsimons T, Holzgreve H, Hosie J, et al., on behalf of the Heart Attack Primary Prevention in Hypertension Trial Research Group. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987; 5:561-572.
22. Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: beta-adrenergic receptor blockers and weight gain. A systematic analysis. Hypertension 2001; 37:250-254.
23. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990; 4:2881-2889.
24. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, et al. Heart rate as marker of sympathetic activity. J Hypertens 1998; 16:1635-1639.
25. Dell'Oro R, Turri C, Bertinieri G, Stella ML, Bolla GB, Grassi G, et al. Does heart rate reflect acute changes in sympathetic cardiovascular drive? J Hypertens 2000; 18 (suppl 2):S147.